308 related articles for article (PubMed ID: 19429480)
1. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.
Dworkin AM; Huang TH; Toland AE
Semin Cancer Biol; 2009 Jun; 19(3):165-71. PubMed ID: 19429480
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.
Kikuchi M; Katoh H; Waraya M; Tanaka Y; Ishii S; Tanaka T; Nishizawa N; Yokoi K; Minatani N; Ema A; Kosaka Y; Tanino H; Yamashita K; Watanabe M
Cancer Lett; 2017 Jan; 384():70-78. PubMed ID: 27756570
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter CpG methylation and its translational applications in breast cancer.
Xiang TX; Yuan Y; Li LL; Wang ZH; Dan LY; Chen Y; Ren GS; Tao Q
Chin J Cancer; 2013 Jan; 32(1):12-20. PubMed ID: 22059908
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of epigenetics in breast cancer - A review.
Bhat SA; Majid S; Wani HA; Rashid S
Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
[TBL] [Abstract][Full Text] [Related]
7. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
Harahap WA; Sudji IR; Nindrea RD
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics as a therapeutic target in breast cancer.
Connolly R; Stearns V
J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
14. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
15. Epigenomics and breast cancer.
Lo PK; Sukumar S
Pharmacogenomics; 2008 Dec; 9(12):1879-902. PubMed ID: 19072646
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
[TBL] [Abstract][Full Text] [Related]
17. Cancer epigenetics: a perspective on the role of DNA methylation in acquired endocrine resistance.
Trimarchi MP; Mouangsavanh M; Huang TH
Chin J Cancer; 2011 Nov; 30(11):749-56. PubMed ID: 22035855
[TBL] [Abstract][Full Text] [Related]
18. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
Arif T; Anwar N
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response.
Pathiraja TN; Stearns V; Oesterreich S
J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):35-47. PubMed ID: 20101445
[TBL] [Abstract][Full Text] [Related]
20. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]